Literature DB >> 10569796

Analysis of antibody response to invariable regions of VlsE, the variable surface antigen of Borrelia burgdorferi.

F T Liang1, M T Philipp.   

Abstract

VlsE, the variable surface antigen of Borrelia burgdorferi, consists of two invariable domains at the amino and carboxyl termini and one central variable domain. The latter contains six invariable regions, IR(1) to IR(6), and six variable regions. In the present study, the antigenicity of all of the invariable regions in B. burgdorferi-infected monkeys, humans, and mice was assessed by peptide-based enzyme-linked immunosorbent assays. Only one invariable region, IR(6), was antigenic in all animals of the three host species. IR(2) and IR(4) were also antigenic in mice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10569796      PMCID: PMC97088          DOI: 10.1128/IAI.67.12.6702-6706.1999

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Variable and conserved structural elements of trypanosome variant surface glycoproteins.

Authors:  D M Reinitz; B D Aizenstein; J M Mansfield
Journal:  Mol Biochem Parasitol       Date:  1992-03       Impact factor: 1.759

Review 2.  Molecular genetics of antigenic variation.

Authors:  P Borst
Journal:  Immunol Today       Date:  1991-03

3.  Crossreacting determinants in the C-terminal region of trypanosome variant surface antigens.

Authors:  G A Cross
Journal:  Nature       Date:  1979-01-25       Impact factor: 49.962

Review 4.  Molecular basis for trypanosome antigenic variation.

Authors:  P Borst; G A Cross
Journal:  Cell       Date:  1982-06       Impact factor: 41.582

5.  Crossreacting determinants in variant-specific surface antigens of African trypanosomes.

Authors:  A F Barbet; T C McGuire
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

6.  An immunodominant conserved region within the variable domain of VlsE, the variable surface antigen of Borrelia burgdorferi.

Authors:  F T Liang; A L Alvarez; Y Gu; J M Nowling; R Ramamoorthy; M T Philipp
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

7.  Antigenic variation is associated with DNA rearrangements in a relapsing fever Borrelia.

Authors:  J T Meier; M I Simon; A G Barbour
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

8.  Intragenic recombination leads to pilus antigenic variation in Neisseria gonorrhoeae.

Authors:  P Hagblom; E Segal; E Billyard; M So
Journal:  Nature       Date:  1985 May 9-15       Impact factor: 49.962

9.  Variable major proteins of Borrelia hermsii. Epitope mapping and partial sequence analysis of CNBr peptides.

Authors:  P A Barstad; J E Coligan; M G Raum; A G Barbour
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

10.  Antigenic variation of Borrelia hermsii.

Authors:  H G Stoenner; T Dodd; C Larsen
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307

View more
  29 in total

1.  Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues.

Authors:  Gereon Goettner; Ulrike Schulte-Spechtel; Ruth Hillermann; Gabi Liegl; Bettina Wilske; Volker Fingerle
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 2.  Microbial antigenic variation mediated by homologous DNA recombination.

Authors:  Cornelis Vink; Gloria Rudenko; H Steven Seifert
Journal:  FEMS Microbiol Rev       Date:  2012-01-17       Impact factor: 16.408

3.  Antibody Response to Lyme Disease Spirochetes in the Context of VlsE-Mediated Immune Evasion.

Authors:  Artem S Rogovskyy; David C Gillis; Yurij Ionov; Ekaterina Gerasimov; Alex Zelikovsky
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

4.  Inflammation in the pathogenesis of lyme neuroborreliosis.

Authors:  Geeta Ramesh; Peter J Didier; John D England; Lenay Santana-Gould; Lara A Doyle-Meyers; Dale S Martin; Mary B Jacobs; Mario T Philipp
Journal:  Am J Pathol       Date:  2015-04-16       Impact factor: 4.307

5.  Immunological Responses to the Relapsing Fever Spirochete Borrelia turicatae in Infected Rhesus Macaques: Implications for Pathogenesis and Diagnosis.

Authors:  Monica E Embers; Aparna Krishnavajhala; Brittany A Armstrong; Michael W Curtis; Bapi Pahar; Hannah K Wilder; Michael S Allen; Paul A Beare; Nicole R Hasenkampf; Job E Lopez
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

6.  Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses.

Authors:  Fang Ting Liang; Jun Yan; M Lamine Mbow; Steven L Sviat; Robert D Gilmore; Mark Mamula; Erol Fikrig
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

7.  Occurrence of Dirofilaria immitis and tick-borne infections caused by Anaplasma phagocytophilum, Borrelia burgdorferi sensu lato and Ehrlichia canis in domestic dogs in France: results of a countrywide serologic survey.

Authors:  Nikola Pantchev; Roland Schaper; Sandy Limousin; Nina Norden; Miriam Weise; Leif Lorentzen
Journal:  Parasitol Res       Date:  2009-08       Impact factor: 2.289

8.  Dogs vaccinated with common Lyme disease vaccines do not respond to IR6, the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi.

Authors:  Thomas P O'Connor; Kathy J Esty; Jancy L Hanscom; Paulette Shields; Mario T Philipp
Journal:  Clin Diagn Lab Immunol       Date:  2004-05

9.  Quantitative measurement of C6 antibody following antibiotic treatment of Borrelia burgdorferi antibody-positive nonclinical dogs.

Authors:  Steven A Levy; Thomas P O'Connor; Jancy L Hanscom; Paulette Shields; Leif Lorentzen; Anthony A Dimarco
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

10.  Possible role of glial cells in the onset and progression of Lyme neuroborreliosis.

Authors:  Geeta Ramesh; Juan T Borda; Amy Gill; Erin P Ribka; Lisa A Morici; Peter Mottram; Dale S Martin; Mary B Jacobs; Peter J Didier; Mario T Philipp
Journal:  J Neuroinflammation       Date:  2009-08-25       Impact factor: 9.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.